Teva Pharmaceutical Industries Ltd. (TEVA): Operating Sales Margin

Public company logo of Teva (TEVA)

The global ecosystem of Teva Pharmaceutical Industries (TEVA) integrates the production of original biologics and generics, creating a reliable sales channel. Operating margin fluctuations confirm the resilience of this model, with the indicator holding at 19.20. Efficiency is supported by decentralized manufacturing, which reduces transportation costs. Stability is further ensured by the absence of key scientist attrition and the targeted hiring of biosimilar specialists.

TEVA: Teva Pharmaceuticals Operating Margin 07/04/2022 - 11/20/2026

Teva Pharmaceutical Industries Ltd. (TEVA) - metric breakdowns and financial figures

- share price and consensus valuation forecast:
Fundamental company valuation:Teva, TEVA
Core merchandise of Teva Pharma

Operating margin measures the share of profit from core operations before financial expenses and taxes, demonstrating the efficiency of internal cost management. Analyzing the operating profit margin reveals how biosimilar sales growth and reduced generic costs at Teva Pharmaceutical Industries (TEVA) are boosting core profitability, establishing the foundation for realizing the long-term potential of the company's innovative portfolio.